You are here

New York Hospital Begins Posting Online Patient Reviews of Physicians

Ratings cover providers in ambulatory settings

The North Shore–LIJ Medical Group, one of the nation’s largest multispecialty group practices, has begun posting online patient reviews of its doctors, the first large medical group in the New York metropolitan area to do so.

The physician ratings are based on surveys collected and monitored by a certified Centers for Medicare & Medicaid Services (CMS) vendor, Press Ganey. This is in contrast to Yelp, Healthgrades, and other physician rating sites that are open to anyone to rate a doctor, whether they saw the doctor or not.

The survey gives patients the opportunity to provide comments about their interaction during the visit and to rate physicians on a 1-to-5 scale on the following qualities:


  • How well they explained the patient’s problem/condition

  • Their concern for the patient’s questions or worries

  • Their efforts to include the patient in treatment decisions

  • How clearly they explained information about medications

  • Their instructions on follow-up care

  • The degree to which they used words the patient could understand

  • The amount of time they spent with the patient

  • The patient’s confidence in the physician

  • The likelihood to recommend the physician

The patient reviews posted on North Shore–LIJ’s “Find-A-Doctor” profile pages reflect 18 months of survey data. The program screens only for patient privacy and unsuitable language, if necessary.

However, while the Medical Group includes more than 2,300 physicians, the ratings are available only for approximately 900 doctors who provide care in ambulatory settings, mostly in outpatient offices outside the health system’s 19 hospitals. It does not include specialists, such as radiologists, and other physicians, such as neonatologists and hospitalists, who provide patient care only in inpatient settings.

Source: North Shore–LIJ; August 27, 2015.

More Headlines

Bone Marrow Cleared of Leukemia in Almost 60% of Patients
Combination of Two Drugs Could Reduce Tumor Growth
First and Only Treatment Reduces Depressive Symptoms Within Days
Atezolizumab in Combination with Chemotherapy is the Only First-line Cancer Immunotherapy for ES-SCLC
Pre-clinical Trials Showed Drug Inhibits Fibroblast Activity and Collagen Deposition
PARG Inhibitor Exploits Weakness, Kills Cells
Inexpensive, Wearable Therapy Increases Arm Mobility, Reduces Stiffness
National Statistics Report Factors In Race, Ethnicity for the First Time